Evidence map›Paper›PMID 39699188›Full record

ArticleJournal of clinical microbiology2025

Low concordance between QIAreach QuantiFERON-TB, a novel interferon-gamma release assay, and QuantiFERON-TB Gold Plus, in a population-based survey in Blantyre, Malawi.

Hannah M Rickman, Mphatso D Phiri, Hannah Mbale, Katherine C Horton, Marc Y R Henrion, Emily S Nightingale, James A Seddon, Elizabeth L Corbett, Peter MacPherson

Abstract readEvaluation StudyComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Frontiers in medicine · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hannah M RickmanClinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0002-3502-0744
Mphatso D PhiriMalawi Liverpool Wellcome Programme, Blantyre, Malawi.
Hannah MbaleMalawi Liverpool Wellcome Programme, Blantyre, Malawi.
Katherine C HortonDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Marc Y R HenrionMalawi Liverpool Wellcome Programme, Blantyre, Malawi.
Emily S NightingaleDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
James A SeddonDesmond Tutu TB Centre, Stellenbosch University, Stellenbosch, South Africa.
Elizabeth L CorbettClinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Peter MacPhersonClinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Funding

Foreign, Commonwealth and Development Office (FCDO) 2018/S 196-443482Wellcome TrustWellcome Trust (WT) 225482/Z/22/Z 200901/Z/16/Z 206575/Z/17/Z
6 · The paper itself

Abstract

Urgent improvements in the diagnosis and management of IMPORTANCE: Almost a quarter of the world's population has evidence of

Indexed as

Interferon-gamma Release TestsTuberculosisAdolescentAdultChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMalawiMaleMycobacterium tuberculosisSensitivity and SpecificityYoung AdultIGRALatent TBMtb infectionMycobacterium tuberculosisQIAreachtuberculosis

Identifiers

PMID39699188
PMCPMC11784431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.